Search hospitals > Maryland > Baltimore
University of Maryland
Claim this profileBaltimore, Maryland 21201
Global Leader in Heart Failure
Global Leader in High Blood Pressure
Conducts research for Human Immunodeficiency Virus Infection
Conducts research for Stroke
Conducts research for Infections
618 reported clinical trials
118 medical researchers
Summary
University of Maryland is a medical facility located in Baltimore, Maryland. This center is recognized for care of Heart Failure, High Blood Pressure, Human Immunodeficiency Virus Infection, Stroke, Infections and other specialties. University of Maryland is involved with conducting 618 clinical trials across 995 conditions. There are 118 research doctors associated with this hospital, such as Hyun Kim, Ranee Mehra, MD, Mark Mishra, MD, and Bradley Taylor, M.D.Top PIs
Hyun KimWashington University School of Medicine3 years of reported clinical research
Studies Pulmonary Fibrosis
Studies Fibrosis
30 reported clinical trials
42 drugs studied
Ranee Mehra, MDUniversity of Maryland/Greenebaum Cancer Center5 years of reported clinical research
Expert in Cancer
Expert in Squamous Cell Carcinoma
20 reported clinical trials
33 drugs studied
Mark Mishra, MDUniversity of Maryland/Greenebaum Cancer Center1 year of reported clinical research
Studies Brain Tumor
Studies Glioblastoma
19 reported clinical trials
43 drugs studied
Bradley Taylor, M.DUniversity of Maryland Medical Center2 years of reported clinical research
Studies Aortic Aneurysm
Studies Mitral Valve Regurgitation
10 reported clinical trials
13 drugs studied
Clinical Trials running at University of Maryland
Prostate Cancer
Non-Hodgkin's Lymphoma
Multiple Myeloma
Stroke
Migraine
Lymphoma
Schizophrenia
Plasma Cell Neoplasms
Bleeding
Diffuse Large B-Cell Lymphoma
Radium-223 + Docetaxel
for Prostate Cancer
This study is evaluating whether a radioactive drug may help treat prostate cancer.
Recruiting2 awards Phase 323 criteria
Lu-177 Ludotadipep
for Prostate Cancer
Phase 1: The objective of the Phase 1 part of the clinical trial is to verify safety and tolerability (dose-limiting toxicity [DLT], maximum tolerated dose [MTD]) of a single 3.7 Giga-Becquerel (GBq) dose with the potential for one dose level de-escalation to 2.775 GBq if necessary, to determine the recommended [177Lu]Ludotadipep dose for use in the Phase 2a part of the trial. Phase 2a: The objective of the Phase 2a part of the trial is to evaluate safety and efficacy for repeated administration of the recommended [177Lu]Ludotadipep dose. The Recommended Phase 2 dose (RP2D) will be based on the study results from the Phase 1 trial in South Korea upon consultation with the FDA.
Recruiting2 awards Phase 1 & 2
Time-Restricted Eating
for Prostate Cancer Survivorship
Frailty is one of the main reasons older adults lose independence. Frailty describes a reduced ability to withstand stress on the physiological scale, or a reduced physiological reserve. The theory is that entrainment of circadian rhythm via time-restricted eating will improve the body's ability to predict energy supply and demand, and therefore enable the body to allocate more resources to anabolic processes and promote resilience to cancer treatment, thereby preventing the progression of frailty. A total of 30 individuals over 55 years old undergoing ADT therapy for prostate cancer will be recruited. Participants will be randomized 1:1 to a 12-week TRE intervention or a time-unrestricted nutrition control intervention. At baseline and post-intervention, Fried's Frailty Index will be used to assess frailty, and a novel set of five physiological responsiveness measures will be used to assess physiological responsiveness-1) lying-to-standing blood pressure, 2) heart rate variability, 3) oral glucose tolerance test, 4) 24-hour circadian cortisol rhythm, and 5) usual vs. fast gait speed. These data will allow assessment of 1) the feasibility of TRE among patients with prostate cancer during ADT treatment with the ultimate goal of optimizing an intervention to prevent the progression of frailty, and 2) the effects of TRE vs. control on frailty and physiological responsiveness.
Recruiting1 award Phase 1 & 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Maryland?
University of Maryland is a medical facility located in Baltimore, Maryland. This center is recognized for care of Heart Failure, High Blood Pressure, Human Immunodeficiency Virus Infection, Stroke, Infections and other specialties. University of Maryland is involved with conducting 618 clinical trials across 995 conditions. There are 118 research doctors associated with this hospital, such as Hyun Kim, Ranee Mehra, MD, Mark Mishra, MD, and Bradley Taylor, M.D.
Where is University of Maryland located?
**Directions to University of Maryland Medical Center, Baltimore:**
- From I-95 North, take Rt. 395 towards downtown Baltimore.
- Exit onto Martin Luther King, Jr., Blvd., and turn right at the fourth traffic light onto Baltimore St.
- Turn left at the second traffic light onto Paca St. Visitor parking is available immediately on the right at the Baltimore Grand Garage.
Who should I call to ask about financial aid or insurance network?
For hospital billing inquiries, reach out to the University of Maryland Medical System Patient Financial Services Office at 410-821-4140. For questions regarding physician services billing, dial 410-528-5710. For financial assistance or inquiries about reduced-cost medically necessary care, contact 410-528-5710 or 888-243-8890. University students seeking financial assistance should call 410-706-7347.
What insurance does University of Maryland accept?
The University of Maryland offers comprehensive insurance coverage across its facilities:
- The Faculty Practice at the University of Maryland, Baltimore, accepts many dental insurance companies, including United Concordia PPO, but not United Concordia DHMO or any HMO plans.
- The University of Maryland Baltimore Washington Medical Center and the University of Maryland Medical Center accept a wide range of insurance providers, including Aetna, Amerigroup, Blue Cross Blue Shield, and many managed care plans. Services at UM Children's Hospital and UM Greenebaum Comprehensive Cancer Center are covered.
- The University Health Center, serving students, faculty, and staff, is in network with Aetna, Blue Cross Blue Shield, Carefirst, United Health Care, Cigna, and Maryland Medicaid, but cannot file claims with Medicare, Kaiser Permanente, Out of State Medicaid, and some HMO plans.
Patients are advised to verify their insurance coverage and any necessary authorizations or referrals before scheduling appointments.
What awards or recognition has University of Maryland received?
The University of Maryland Medical Center in Baltimore, Maryland, is renowned for its specialty care in Ear, Nose & Throat and Pediatric Cardiology & Heart Surgery, earning a spot in the U.S. News & World Report Best Hospital rankings for five consecutive years. It has also been awarded the American Heart Association/American Stroke Association’s Get With The Guidelines® Target: Stroke Honor Roll Elite Plus Gold Plus Quality Achievement Award. This accolade highlights the center's dedication to delivering stroke patients with treatment that adheres to nationally recognized guidelines.